You have 9 free searches left this month | for more free features.

ponatinib

Showing 1 - 25 of 40

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Frankfurt (Imatinib, Ponatinib, Blinatumomab)

Recruiting
  • Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
  • Frankfurt, Germany
    Department of Medicine, Hematology and Oncology, Goethe Universi
Sep 24, 2023

Acute Lymphoblastic Leukemia, Leukemia Trial in Houston (Ponatinib, Venetoclax, Mini-hyper CVD)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Leukemia
  • Ponatinib
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Aug 23, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

ALL Trial in Spain (Prednisone, Vincristine, Daunorubicin)

Active, not recruiting
  • ALL
  • Badalona, Spain
  • +9 more
Feb 17, 2022

Medullary Thyroid Cancer Trial (Ponatinib)

Withdrawn
  • Medullary Thyroid Cancer
  • Ponatinib
  • (no location specified)
Oct 6, 2021

Adenocarcinoma of the Lung, Extensive Stage Small Cell Lung Cancer, Limited Stage Small Cell Lung Cancer Trial in Aurora

Completed
  • Adenocarcinoma of the Lung
  • +7 more
  • Ponatinib
  • Aurora, Colorado
    University of Colorado Cancer Center
Jan 19, 2022

Leukemia, Myeloid, Chronic-Phase Trial in Germany (Ponatinib)

Active, not recruiting
  • Leukemia, Myeloid, Chronic-Phase
  • Ponatinib
  • Halle (Saale), Saxony-Anhalt, Germany
  • +9 more
Sep 9, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +7 more
  • Blinatumomab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

CML Patients in the National Compassionate Program

Terminated
  • Chronic Myeloid Leukemia
  • Philadelphia Positive
  • Ponatinib
  • Bari, Italy
  • +9 more
Oct 24, 2022

Acute Lymphoblastic Leukemia Trial in Ann Arbor (Dasatinib, Ponatinib, Berlin-Frankfurt-Münster Chemotherapy)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Nov 28, 2022

Acute Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blast Phase Chronic Myeloid Leukemia Trial in Worldwide

Recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Ponatinib
  • Ghent, Belgium
  • +28 more
Nov 11, 2022

Landscape and Real-life Treatment Outcomes in Hungary: Analysis

Completed
  • Chronic Myeloid Leukaemia
  • Budapest, Hungary
    Pfizer
Dec 15, 2022

Philadelphia Chromosome Positive CML, BCR-ABL Positive Chronic Myelogenous Leukemia Trial in France (Ponatinib, Imatinib)

Recruiting
  • Philadelphia Chromosome Positive CML
  • BCR-ABL Positive Chronic Myelogenous Leukemia
  • Amiens, France
  • +27 more
Dec 9, 2021

Philadelphia-Positive ALL, Acute Lymphoblastic Leukemia, in Relapse Trial in Italy (Ponatinib)

Recruiting
  • Philadelphia-Positive ALL
  • Acute Lymphoblastic Leukemia, in Relapse
  • Ponatinib
  • Ancona, Italy
  • +21 more
Jan 3, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia With

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +5 more
  • Blinatumomab
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2022

Chronic Myeloid Leukemia, Chronic Phase, Adults Trial in Italy (Ponatinib)

Active, not recruiting
  • Chronic Myeloid Leukemia
  • +2 more
  • Ponatinib
  • Alessandria, Italy
  • +36 more
Jan 4, 2022

Iclusig PMS in CML or Ph+ALL Patients

Recruiting
  • Chronic Myeloid Leukemia
  • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
  • Ponatinib
  • Busan, Korea, Republic of
    Kosin University Gaspel Hospital
Sep 16, 2021

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2022

Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL), Ph+ Mixed Phenotype Acute Leukemia (MPAL),

Recruiting
  • Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL)
  • +2 more
  • Ponatinib
  • +2 more
  • Phoenix, Arizona
  • +69 more
Aug 23, 2022

Acute Lymphoblastic Leukemia, Adult Trial (Ponatinib, Blinatumomab, Imatinib)

Not yet recruiting
  • Acute Lymphoblastic Leukemia, Adult
  • Ponatinib
  • +2 more
  • (no location specified)
Dec 28, 2020

Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, ph+ Acute Lymphoblastic Leukemia Trial in Chicago (Inotuzumab ozogamicin,

Recruiting
  • Lymphoblastic Leukemia
  • +2 more
  • Inotuzumab ozogamicin
  • +7 more
  • Chicago, Illinois
    University of Chicago Medical Center
May 16, 2022

Philadelphia Positive, BCR-ABL Positive, Acute Lymphoblastic Leukemia Trial in Italy (Ponatinib)

Completed
  • Philadelphia Positive
  • +2 more
  • Ponatinib
  • Alessandria, Italy
  • +41 more
Nov 18, 2021

Chronic Myeloid Leukemia, Ph+ Acute Lymphoblastic Leukemia Trial in Worldwide (Ponatinib)

Completed
  • Chronic Myeloid Leukemia
  • Ph+ Acute Lymphoblastic Leukemia
  • Ponatinib
  • St Leonards, New South Wales, Australia
  • +41 more
Jan 18, 2021

CHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE, CHRONIC MYELOGENOUS LEUKAEMIA IN MYELOID BLAST CRISIS Trial in France

Recruiting
  • CHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE
  • CHRONIC MYELOGENOUS LEUKAEMIA IN MYELOID BLAST CRISIS
  • Amiens, France
  • +28 more
Aug 6, 2020

Myeloid Leukemia, Chronic, Chronic Phase Trial in Worldwide (Ponatinib)

Active, not recruiting
  • Myeloid Leukemia, Chronic, Chronic Phase
  • Ponatinib
  • Atlanta, Georgia
  • +85 more
Jan 4, 2022